Suggestions
Chris Loryman
Senior Manager at UC San Diego Office of Innovation & Commercialization
Professional Background
Chris Loryman is a seasoned professional with over 20 years of extensive experience in the fields of biotechnology and medical devices. Having held various pivotal roles in industry innovation, business planning, and technology transfer, Chris has developed a well-rounded expertise that is instrumental in advancing the development of transformative medical technologies. Currently, Chris serves as the Senior Manager of the Office of Innovation and Commercialization at UC San Diego, where he facilitates the translation of research and discoveries into viable commercial products, ultimately enhancing patient care and fostering innovation in the biotech sector.
In addition to his senior role at UCSD, Chris has made significant contributions to multiple organizations, some of which he co-founded. Notably, he co-founded ThioLogics Ltd in 2009, a London-based company specializing in antibody-drug conjugates—an innovative treatment modality in oncology. This endeavor exemplifies his commitment to harnessing the potential of biotechnology to create effective therapies for patients. Furthermore, Chris has been active in the San Diego community, co-founding the San Diego Innovation Council in 2016 to promote collaboration, innovation, and entrepreneurship within the region's biotech sector.
His impressive career trajectory includes vital positions as a Principal Contract Officer at UCSD, where he managed industry research contracts and physician-initiated clinical trials, ensuring the seamless integration of academic research with industry needs. Before his tenure at UCSD, Chris also excelled as the Senior Business Manager at UCL Business PLC, the technology commercialization arm of University College London. His role involved overseeing innovative projects and initiatives, which required a keen understanding of the commercialization landscape in biotech and medical research.
Moreover, Chris has international experience, having provided operational management for projects across two continents and representing multiple universities. His role as a Senior Scientist at Smith & Nephew allowed him to lead a research lab in La Jolla, where he worked on innovative solutions in the medical device space. Each of these experiences has enriched Chris's capacity to bridge the gap between research, commercialization, and clinical application.
Education and Achievements
Chris Loryman's academic background provides a solid foundation for his professional endeavors in the biotechnology and medical device industries. While specific academic details are not provided, his advanced understanding and application of scientific principles are evident through his roles in research and clinical management. With a personal passion for fostering innovation, Chris continuously seeks out opportunities for professional development and industry engagement.
Throughout his career, Chris has contributed to the successful management of a global clinical trial and consulted on technology commercialization and strategic business development for various organizations. His expertise in raising both dilutive and non-dilutive funding showcases his ability to navigate the complex financial landscapes that companies often face in bringing new technologies to market. Chris's work exemplifies the ideal blend of scientific acumen and entrepreneurial spirit, paving the way for health solutions that embody relevance and impact.
Achievements
- Over 20 years of experience in the biotechnology and medical device industries.
- Senior Manager at UC San Diego's Office of Innovation and Commercialization.
- Co-founded ThioLogics Ltd, focusing on antibody-drug conjugates.
- Cofounder of the San Diego Innovation Council to promote regional biotech innovation.
- Managed a global Phase 3b oncology clinical trial.
- Oversaw industry research contracts and physician-initiated trials at UC San Diego.